Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jun;65(6):2067-73.
doi: 10.1128/iai.65.6.2067-2073.1997.

Reactivation of chlamydial genital tract infection in mice

Affiliations

Reactivation of chlamydial genital tract infection in mice

T W Cotter et al. Infect Immun. 1997 Jun.

Abstract

A model was developed to study chlamydial quiescence in C3H/HeN (C3H) and C57BL/6N (C57) mice following genital tract infection by Chlamydia trachomatis MoPn. Reactivation of chlamydial shedding following immunosuppression indicated that viable MoPn remained in the genital tract for up to 4 or 5 weeks after the apparent clearance of a primary infection. Either cyclophosphamide or cortisone acetate treatment could cause reactivation, but cyclophosphamide was more effective. However, the frequency of reactivation by either drug diminished with time in both mouse strains. Progesterone treatment prior to infection of C57 mice greatly reduced the frequency of reactivation by cyclophosphamide and also correlated with the development of marked fluid accumulation and distension of the uterine horns in the vast majority of those animals. This pathology was apparent by 5 to 7 weeks postinfection and was consistently seen through 110 days postinfection. Neither of these phenomena was observed in C57 mice that had not been treated with progesterone or in C3H mice under any conditions tested. The infecting dose of MoPn did not clearly influence the frequency of reactivation in either inbred strain as defined by this model.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1993 May 1;90(9):3998-4002 - PubMed
    1. Infect Immun. 1993 Feb;61(2):772-6 - PubMed
    1. Microbiol Rev. 1994 Dec;58(4):686-99 - PubMed
    1. J Infect Dis. 1995 Aug;172(2):593-4 - PubMed
    1. Trans Assoc Am Physicians. 1972;85:203-11 - PubMed

Publication types